Other studies reported a significant decrease of CD3+, CD4+, CD8+ cells in patients with severe or critical COVID-19 within 14 days after disease onset, as well as different normalization times for total T-lymphocyte serum levels in moderate vs. severe/critical disease (38 days vs. 49 days, respectively) [13,24]. The gene discussed is CD8A; the disease is COVID-19.